Delayed
NSE India S.E.
05:36:26 26/06/2024 BST
|
5-day change
|
1st Jan Change
|
61.45
INR
|
-0.60%
|
|
-4.20%
|
+19.46%
|
Fiscal Period: March |
2022
|
2023
|
---|
Capitalization
1 |
8,889
|
6,863
|
Enterprise Value (EV)
1 |
8,544
|
7,220
|
P/E ratio
|
18.7
x
|
15.8
x
|
Yield
|
-
|
0.9%
|
Capitalization / Revenue
|
3.55
x
|
2.27
x
|
EV / Revenue
|
3.41
x
|
2.39
x
|
EV / EBITDA
|
16.1
x
|
13
x
|
EV / FCF
|
-31,339,709
x
|
-8,479,149
x
|
FCF Yield
|
-0%
|
-0%
|
Price to Book
|
3.9
x
|
2.56
x
|
Nbr of stocks (in thousands)
|
307,425
|
307,425
|
Reference price
2 |
28.92
|
22.32
|
Announcement Date
|
06/08/22
|
16/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,013
|
1,323
|
1,427
|
1,958
|
2,503
|
3,020
|
EBITDA
1 |
138.8
|
293.2
|
283.7
|
418
|
530
|
557
|
EBIT
1 |
124.9
|
276.5
|
264.5
|
395.3
|
501.4
|
521.2
|
Operating Margin
|
12.33%
|
20.9%
|
18.53%
|
20.19%
|
20.03%
|
17.26%
|
Earnings before Tax (EBT)
1 |
88.05
|
247.3
|
253.4
|
384.8
|
516
|
544.8
|
Net income
1 |
58.02
|
190.1
|
203.2
|
302.6
|
400.4
|
435.4
|
Net margin
|
5.73%
|
14.37%
|
14.24%
|
15.45%
|
16%
|
14.41%
|
EPS
2 |
0.7552
|
2.475
|
2.644
|
3.939
|
1.544
|
1.416
|
Free Cash Flow
|
-
|
13.22
|
-3.896
|
121.4
|
-272.6
|
-851.6
|
FCF margin
|
-
|
1%
|
-0.27%
|
6.2%
|
-10.89%
|
-28.19%
|
FCF Conversion (EBITDA)
|
-
|
4.51%
|
-
|
29.04%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
6.95%
|
-
|
40.11%
|
-
|
-
|
Dividend per Share
2 |
0.0400
|
0.0400
|
0.1000
|
-
|
-
|
0.2000
|
Announcement Date
|
25/05/18
|
03/09/19
|
28/09/20
|
26/08/21
|
06/08/22
|
16/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
276
|
231
|
198
|
29.1
|
-
|
357
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
345
|
-
|
Leverage (Debt/EBITDA)
|
1.986
x
|
0.7864
x
|
0.6976
x
|
0.0696
x
|
-
|
0.6413
x
|
Free Cash Flow
|
-
|
13.2
|
-3.9
|
121
|
-273
|
-852
|
ROE (net income / shareholders' equity)
|
-
|
53.4%
|
37.1%
|
38.1%
|
24.9%
|
17.5%
|
ROA (Net income/ Total Assets)
|
-
|
21.1%
|
16.5%
|
20.4%
|
14.9%
|
9.86%
|
Assets
1 |
-
|
900.7
|
1,233
|
1,485
|
2,684
|
4,414
|
Book Value Per Share
2 |
3.350
|
5.840
|
8.410
|
12.30
|
7.410
|
8.730
|
Cash Flow per Share
2 |
0.3300
|
0.1600
|
1.140
|
2.070
|
0.9500
|
0.4500
|
Capex
1 |
43.9
|
59.4
|
59.3
|
92.8
|
243
|
1,007
|
Capex / Sales
|
4.34%
|
4.49%
|
4.15%
|
4.74%
|
9.72%
|
33.34%
|
Announcement Date
|
25/05/18
|
03/09/19
|
28/09/20
|
26/08/21
|
06/08/22
|
16/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +19.46% | 243M | | +55.19% | 815B | | +47.26% | 654B | | -6.09% | 354B | | +21.92% | 337B | | +18.40% | 247B | | +3.64% | 229B | | +12.98% | 219B | | +10.86% | 171B | | -2.78% | 159B |
Other Pharmaceuticals
|